What's new

Human medicines European public assessment report (EPAR): Uplizna, inebilizumab, Date of authorisation: 25/04/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Uplizna, inebilizumab, Date of authorisation: 25/04/2022, Revision: 5, Status: Authorised

Mar 26, 2025 - 17:05
 0
Human medicines European public assessment report (EPAR): Uplizna, inebilizumab, Date of authorisation: 25/04/2022, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Uplizna, inebilizumab, Date of authorisation: 25/04/2022, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Lopinavir/Ritonavir Vi...

Next Article

EU Implementation Guide (IG) on veterinary medicines product data in the Union P...

Related Posts

Twelfth Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 28 March 2025, 09:00 (CET) to 28 March 2025, 14:00 (CET)

Twelfth Industry Standing Group (ISG) meeting, Online, ...

Feb 9, 2025  0

EMEA-003301-PIP01-22-M01

EMEA-003301-PIP01-22-M01

Feb 17, 2025  0

Rheumatology/Immunology Working Party

Rheumatology/Immunology Working Party

Feb 9, 2025  0